When Cytochrome P450 Inhibition Becomes a Drug Designer’s Best Friend
A new review argues that cytochrome P450 inhibition, long treated as a drug-discovery liability, can be a powerful therapeutic strategy ...
A new review argues that cytochrome P450 inhibition, long treated as a drug-discovery liability, can be a powerful therapeutic strategy ...
A Danish study of 589 mother–child pairs links azole antifungal use in pregnancy to altered adrenal hormone levels in infants, ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine